Sự khác biệt về sự sống còn và các yếu tố tiên lượng giữa những người hút thuốc và những người không hút thuốc với ung thư phổi không tế bào nhỏ giai đoạn muộn

Chen CJ, Wu HY, Chuang YC et al (1990) Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer Res 10:971–976 Toh CK, Gao F, Lim WT et al (2006) Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol 20:2245–2251 Wakelee HA, Chang ET, Gomez SL et al (2007) Lung cancer incidence in never smokers. J Clin Oncol 25:472–478 Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers—a different disease. Nat Rev Cancer 7:778–7790 Subramanian J, Govindan R (2007) Lung cancer in never smokers: a review. J Clin Oncol 10:561–570 Fujisawa T, Iizasa T, Saitoh Y et al (1999) Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 17:2086–2091 Tammemagi CM, Neslund-Dudas C, Simoff M et al (2004) Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 125:27–37 Nordquist LT, Simon GR, Cantor A et al (2004) Improved survival in never-smokers versus current smokers with primary adenocarcinoma of the lung. Chest 126:347–351 Toh CK, Wong EH, Lim WT et al (2004) The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. Chest 126:1750–1756 Kawai H, Tada A, Kawahara M et al (2005) Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer-a multicenter study. Lung Cancer 49:63–70 Tsao AS, Liu D, Lee JJ et al (2006) Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 106:2428–2436 Zhou W, Heist RS, Liu G et al (2006) Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer 53:375–380 Bryant A, Cerfolio RJ (2007) Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer. Chest 132:185–192 Subramanian J, Velcheti V, Gao F et al (2007) Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC). J Thorac Oncol 2:827–830 Itaya T, Yamaoto N, Ando M et al (2007) Influence of histological type, smoking history and chemotherapy on survival after first-line therapy in patients with advanced non-small cell lung cancer. Cancer Sci 98:226–230 Hanagiri T, Sugio K, Mizukami M et al (2008) Significance of smoking as a postoperative prognostic factor in patients with non-small cell lung cancer. J Thorac Oncol 3:1127–1132 Guo NL, Tosun K, Horn K (2009) Impact and interactions between smoking and traditional prognostic factors in lung cancer progression. Lung Cancer 66:386–392 Teramukai S, Kitano T, Kishida Y et al (2009) Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 45:1950–1958 Shepherd FA, Dancey J, Ramlau R et al (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123–132 Thatcher N, Chang A, Parikh P et al (2005) Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 366:1527–1537 Zhang Z, Xu F, Wang S et al (2008) Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer. Lung Cancer 60:434–440 Yanbaeva DG, Dentener MA, Creutzberg EC et al (2007) Systemic effects of smoking. Chest 131:1557–1566 Scott HR, McMillan DC, Forrest LM et al (2002) The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer 87:264–267 Forrest McMillan DC, McArdle CS et al (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 23:1834–1836 Wilop S, Crysandt M, Bendel M et al (2008) Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer. Onkologie 31:665–670 Koch A, Fohlin H, Sörenson S (2009) Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy. J Thorac Oncol 4:326–332 Paesmans M, Sculier JP, Libert P et al (1995) Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 13:1221–1230 Watine J (2000) Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review. Scand J Clin Lab Invest 60:259–274 Nakahara Y, Mochiduki Y, Miyamoto Y et al (2005) Prognostic significance of the lymphocyte-to-neutrophil ratio in percutaneous fine-needle aspiration biopsy specimens of advanced nonsmall cell lung carcinoma. Cancer 104:1271–1280 Mandrekar SJ, Schild SE, Hillman SL et al (2006) A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer 15:781–792 Sarraf KM, Belcher E, Raevsky E et al (2009) Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. Thorac Cardiovasc Surg 137:425–428 Yamamoto K, Matsumoto S, Tada H et al (2008) A data capture system for outcomes studies that integrates with electronic health records: development and potential uses. J Med Syst 32:423–427 Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205–216 Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867 Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444 Lewkowicz P, Lewkowicz N, Sasiak A, Tchorzewski H (2006) Lipopolysaccharide-activated CD4+ CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol 15:7155–7163